Annovis Bio, Inc.
Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
ANVS | NYSE
Overview
Corporate Details
- ISIN(s):
- US03615A1088
- LEI:
- Country:
- United States of America
- Address:
- 101 LINDENWOOD DRIVE, SUITE 225, 19355 MALVERN
- Website:
- https://www.annovisbio.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Annovis Bio, Inc. is a clinical-stage biotechnology company dedicated to developing therapies for neurodegenerative diseases, with a primary focus on Alzheimer's and Parkinson's disease. The company's mission is to halt the death of nerve cells and restore neurological function. Its lead product candidate, Buntanetap, is an orally administered small molecule designed with a unique mechanism of action to inhibit multiple neurotoxic proteins simultaneously. Annovis Bio is pioneering this novel approach to provide transformative treatments for some of the most challenging neurological conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Annovis Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Annovis Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Annovis Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
